Guenancia Charles, Stamboul Karim, Hachet Olivier, Yameogo Valentin, Garnier Fabien, Gudjoncik Aurélie, Cottin Yves, Lorgis Luc
Department of Cardiology, University Hospital, Dijon, France.
LPPCM, INSERM U866, University of Burgundy, Dijon, France.
Heart Vessels. 2016 Jun;31(6):897-906. doi: 10.1007/s00380-015-0695-8. Epub 2015 Jun 6.
We assessed the interest of systematically using the GRACE scoring system (in addition to clinical assessment) for in- hospital outcomes and bleeding complications in the management of NSTEMI compared with clinical assessments alone. Multicentre, randomized study that included 572 consecutive NSTEMI patients, randomized 1:1, into group A: clinical stratification alone and group B: clinical+ GRACE score stratification.
in-hospital outcomes and bleeding complications. There was no significant difference between the two groups for baseline data or for in-hospital MACE. In multivariate analysis, only a GRACE >140 (OR: 3.5, 95 % CI: 1.8-6.6, p < 0.001) and PCI (OR: 0.55, 95 % CI: 0.3-1.0; p = 0.05) were independent predictors of in-hospital MACE. The sub-analysis of group B showed that 56 patients (20 %) were given a compliance score of 0, showing that diagnostic angiography was performed later than as recommended by the guidelines. Interestingly, 91 % had a GRACE score >140, and these patients were significantly older, and were more likely to have a history of diabetes, stroke and renal failure, together with symptoms of heart failure. After multivariate analysis, the independent predictors of a lack of compliance with guideline delays were a GRACE score >140 (OR: 9.2; CI: 4.2-20.3, p < 0.001) and secondary referral from a non-PCI cardiology department (OR: 2.7; CI: 1.4-5.2, p = 0.003). In a real-world setting of patients admitted with NSTEMI, the systematic use of the GRACE scoring system at admission in the PCI centre does not improve in-hospital outcomes and bleeding complications.
我们评估了在非ST段抬高型心肌梗死(NSTEMI)管理中,与仅进行临床评估相比,系统使用GRACE评分系统(除临床评估外)对住院结局和出血并发症的影响。这是一项多中心随机研究,纳入了572例连续的NSTEMI患者,按1:1随机分为A组:仅临床分层;B组:临床+GRACE评分分层。
住院结局和出血并发症。两组的基线数据或住院期间主要不良心血管事件(MACE)无显著差异。多因素分析显示,仅GRACE评分>140(比值比:3.5,95%置信区间:1.8 - 6.6,p<0.001)和经皮冠状动脉介入治疗(PCI)(比值比:0.